930 results on '"Hansen, John‐Bjarne"'
Search Results
2. Transcriptome-wide association study and Mendelian randomization in pancreatic cancer identifies susceptibility genes and causal relationships with type 2 diabetes and venous thromboembolism
3. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
4. The fatty liver index and risk of incident venous thromboembolism: the Tromsø Study
5. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity
6. High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study
7. Joint effect of ischemic stroke and obesity on the risk of venous thromboembolism: the Tromsø Study
8. Proportion of venous thromboembolism attributed to recognized prothrombotic genotypes in men and women
9. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology
10. Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi‐Ethnic Study of Atherosclerosis
11. Combined effect of high factor VIII levels and high mean platelet volume on the risk of future incident venous thromboembolism
12. Plasma levels of P-selectin and future risk of incident venous thromboembolism
13. Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
14. Hand grip strength in venous thromboembolism: risk of recurrence and mortality
15. Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
16. High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism
17. C1 inhibitor deficiency enhances contact pathway–mediated activation of coagulation and venous thrombosis
18. Venous thromboembolism and risk of depression: a population-based cohort study
19. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
20. Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism
21. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism
22. Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
23. Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
24. A large‐scale exome array analysis of venous thromboembolism
25. Identification of Common and Rare Genetic Variation Associated With Plasma Protein Levels Using Whole-Exome Sequencing and Mass Spectrometry
26. Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
27. Multi‐phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations
28. Plasma levels of platelet‐derived microvesicles are associated with risk of future venous thromboembolism
29. Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial
30. A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generation
31. Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death
32. Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
33. Socioeconomic status and risk of incident venous thromboembolism
34. Galectin-3-binding protein and future venous thromboembolism
35. Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism
36. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism
37. Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism
38. Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event
39. The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study.
40. Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
41. Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
42. Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study
43. Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins
44. Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study.
45. “C1-inhibitor levels and Venous Thromboembolism: Results from a Mendelian Randomization Study”: comment from Grover et al
46. Sustained and intermittent hypoxia differentially modulate primary monocyte immunothrombotic responses to IL-1β stimulation
47. Cardiorespiratory fitness and future risk of venous thromboembolism
48. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
49. Plasma levels of mannose‐binding lectin and future risk of venous thromboembolism
50. Consanguinity and rare mutations outside of MCCC genes underlie nonspecific phenotypes of MCCD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.